Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study

British Journal of Cancer 2026 Open access

Read full text
Authors: Benoit Blanchet, Alicja Puszkiel, Anne Jouinot, M. Bennamoun, Denis Maillet, D. Borchiellini, Brigitte Laguerre, Diane Pannier, Marine Gross-Goupil, Christine Chevreau, Philippe Barthélémy, Christophe Tournigand
+8 more E. Coquan, Gwénaëlle Gravis, Eve M. Lepicard, Wolf Herman Fridman, Catherine Sautès-Fridman, S. Oudard, Cheng-Ming Sun, Yann-Alexandre Vano
DOI: 10.1038/s41416-026-03340-1
Cited by: 1
References: 40

Fields of Study & Subjects

Renal cell carcinoma treatment Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis

Publication details

Journal / source
British Journal of Cancer
Publisher
Springer Science and Business Media LLC
Volume
134
Issue
8
Pages
1166–1175
Publication date
6 February 2026
Language
EN